Bone density (DXA) screening for osteoporosis: Should you get it? How to interpret T-scores? Who needs it?
Osteoporosis is a condition of bone loss, weakened bones, and increased fracture risk, often called a 'silent disease'—usually no symptoms until a fall or collision causes a hip, spine, or wrist fracture. The reference standard for bone density measurement is dual-energy X-ray absorptiometry (DXA), interpreted using T-scores: T-score ≥ −1.0 is normal, −1.0 to −2.5 is low bone mass (osteopenia), ≤ −2.5 is osteoporosis. Whether screening or treatment is needed should be determined by a physician based on individual risk, DXA results, and fracture risk assessment (FRAX). Screening recommendations follow HPA and osteoporosis society guidelines. This is neutral information, not medical advice.
What is osteoporosis? Why is it called the 'silent disease'
Osteoporosis is a condition of decreased bone mass and bone strength, increasing fracture risk, characterized by usually having no symptoms:
- Often no symptoms until a fracture occurs at the hip, spine, or wrist; vertebral compression fractures may cause height loss or kyphosis
- After menopause, due to estrogen decline, bone loss accelerates, making women an important risk group
- Key point: fractures (especially hip) significantly impact mobility and health in older adults; early awareness of risk is beneficial
How is bone density measured? Understanding DXA, T-scores, and Z-scores
The reference standard for bone mineral density (BMD) is DXA (dual-energy X-ray absorptiometry), commonly measuring the lumbar spine and hip, with very low radiation:
- T-score: compared to young healthy adults. ≥ -1.0 normal; -1.0 to -2.5 low bone mass (osteopenia); ≤ -2.5 osteoporosis (for postmenopausal women and men aged 50+)
- Z-score: used for premenopausal women, men under 50, and children; ≤ -2.0 indicates 'below expected for age'; in this group, osteoporosis diagnosis cannot rely solely on BMD numbers and requires clinical evaluation
- 'Low bone mass (osteopenia)' is not 'osteoporosis' and does not necessarily require medication—interpretation and follow-up should be done by a physician
Who needs a bone density test?
Screening targets depend on risk; not everyone needs annual testing:
- US USPSTF recommends: screening for women aged 65+; for postmenopausal women under 65 with high risk based on risk assessment (no clear recommendation for men due to insufficient evidence)
- In Taiwan (per the Health Promotion Administration and the Taiwanese Osteoporosis Association): it is often mentioned that women aged about 65+ and men aged about 70+, or younger individuals with risk factors or a history of fragility fractures, should be screened; actual recommendations should follow the latest HPA announcement.
- Common risk factors: advanced age, menopause, low body weight, prior fracture, parental hip fracture, long-term steroid use, smoking, excessive alcohol, rheumatoid arthritis or hyperthyroidism, insufficient calcium and vitamin D, etc.; physicians may also use FRAX (with Taiwan model) to estimate 10-year fracture risk as an aid.
Is the 'heel ultrasound bone density' in health checkups equivalent to a diagnosis?
Heel ultrasound (QUS) commonly found in pharmacies, health checkups, or community settings differs from DXA; be aware:
- Heel ultrasound (QUS) is inexpensive and radiation-free, but it is only a 'preliminary screening' tool and cannot diagnose osteoporosis using the WHO T-score criteria.
- If ultrasound results are low, further DXA is recommended for confirmation; do not self-diagnose based on a single number.
- It is not 'the more scans the better': normal results usually do not require annual retesting; repeat intervals are often about every 2 years, depending on risk, physician advice, and NHI coverage conditions.
Can osteoporosis be prevented? What to do after screening?
Bone health can be addressed through lifestyle; screening results should be interpreted by a physician to determine next steps:
- General bone health: adequate calcium and vitamin D, regular weight-bearing and resistance exercise, no smoking, limit alcohol, fall prevention at home.
- Whether medication is needed is a decision made by the physician based on DXA, FRAX risk, and fracture history; this page does not recommend specific drugs or claim outcomes.
- Osteoporosis is a manageable chronic condition; if concerned or at high risk, discuss screening and follow-up with a physician, and follow the latest HPA announcements.
FAQ
What is a bone density test (DXA)? Is it accurate?
The reference standard for bone mineral density (BMD) is DXA (dual-energy X-ray absorptiometry), typically measuring the lumbar spine and hip, with very low radiation exposure. It uses T-scores to assess bone status and is the international basis for diagnosing osteoporosis. Heel ultrasound (QUS) commonly found in pharmacies or health checkups is a preliminary screening tool and cannot be used for diagnosis; if results are low, confirm with DXA. This page provides neutral information, not medical advice.
How to interpret bone density T-scores? What counts as osteoporosis?
For postmenopausal women and men aged 50 and older: T-score ≥ -1.0 is normal; between -1.0 and -2.5 is low bone mass (osteopenia); ≤ -2.5 is osteoporosis. The T-score compares to young healthy adults. For premenopausal women, men under 50, and children, use Z-scores, and diagnosis should not rely solely on numbers but requires clinical evaluation. Low bone mass is not osteoporosis and does not necessarily require medication.
Who needs a bone density test? At what age?
It depends on risk. The US USPSTF recommends screening for women aged 65 and older, and for postmenopausal women under 65 with high risk. In Taiwan (per the Health Promotion Administration and Osteoporosis Society), screening is often mentioned for women around 65 and older, men around 70 and older, or younger individuals with risk factors or prior fragility fractures; refer to the latest official guidelines. Those with risk factors should discuss with their doctor.
Is the heel ultrasound bone density test at pharmacies or health checkups reliable?
Heel ultrasound (QUS) is inexpensive and radiation-free, making it a convenient 'preliminary screening' tool, but it cannot diagnose osteoporosis using WHO T-score criteria, has limited correlation with DXA, and may miss some abnormalities. If results are low, follow up with DXA for confirmation; do not self-diagnose based on a single number.
How often should a bone density test be done?
More frequent is not better. Normal results usually do not require annual retesting; repeat intervals are often about every 2 years, depending on individual risk, proximity to thresholds, treatment status, and physician advice or insurance coverage. Annual scanning for normal results is not evidence-supported.
If low bone mass or osteoporosis is found, is medication necessary?
Not necessarily. Low bone mass (osteopenia) is not osteoporosis; the decision to use medication is made by a physician based on DXA values, FRAX fracture risk, and fracture history. Lifestyle measures can also help: adequate calcium and vitamin D, weight-bearing and resistance exercise, no smoking, limited alcohol, and fall prevention at home. Consult your doctor if in doubt; this page does not recommend specific drugs.
This page is a neutral compilation of information for reference only, not Medical advice, and does not constitute any diagnostic commitment.